FDA Drug Recalls

Recalls / Class II

Class IID-0904-2023

Product

aller-ease, Fexofenadine Hydrochloride Tablets, 180 mg, 30-count cartons, Packaged For: Your Military Exchanges, By: Perrigo Company, Allegan, MI USA 49010. NDC 55301-847-39

Brand name
Exchange Select Aller Ease
Generic name
Fexofenadine Hydrochloride
Active ingredient
Fexofenadine Hydrochloride
Route
Oral
NDC
55301-847
FDA application
ANDA212971
Affected lot / code info
Lot #: 2ER0285,Exp. date 01/24

Why it was recalled

Failed Impurities/Degradation Specifications

Recalling firm

Firm
L. Perrigo Company
Manufacturer
Army & Air Force Exchange Service
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
515 Eastern Ave, N/A, Allegan, Michigan 49010-9070

Distribution

Quantity
1,920 cartons
Distribution pattern
Nationwide within the USA

Timeline

Recall initiated
2023-02-09
FDA classified
2023-07-11
Posted by FDA
2023-07-19
Terminated
2023-09-11
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0904-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.